Senescence-induced T cell dysfunction in the TME impedes the clinical efficacy of cancer immunotherapy.9 14 An age-dependent accumulation of senescent T cells in healthy individuals which was associated with changes in expression of T cell surface markers and p53 isoforms has been described. The gene discussed is TP53; the disease is cancer.